Ke Shen

938 total citations
28 papers, 742 citations indexed

About

Ke Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ke Shen has authored 28 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Ke Shen's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Ke Shen is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Ke Shen collaborates with scholars based in China, United States and New Zealand. Ke Shen's co-authors include Jianwen Liu, Raymond Novak, Lei Ni, Peihao Yin, Xin Liang, Ke Xu, Yueqi Li, Ke Xu, Yanhua Lu and Qi Li and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Ke Shen

26 papers receiving 730 citations

Peers

Ke Shen
Dapeng Ding China
Chuangyu Wen China
Wuguo Li China
Ming‐De Yan Taiwan
Sabnam Parbin India
Pingli Mo China
Yujie Sun China
Xiaohua Zhang China
Yidi Guan China
Dapeng Ding China
Ke Shen
Citations per year, relative to Ke Shen Ke Shen (= 1×) peers Dapeng Ding

Countries citing papers authored by Ke Shen

Since Specialization
Citations

This map shows the geographic impact of Ke Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Shen more than expected).

Fields of papers citing papers by Ke Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Shen. The network helps show where Ke Shen may publish in the future.

Co-authorship network of co-authors of Ke Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Shen. A scholar is included among the top collaborators of Ke Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Shen. Ke Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandon, William, et al.. (2025). A Case of Massive Pleural Effusion Due to Azacitidine Therapy. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1924–A1924.
2.
Bao, Chunyang, et al.. (2025). Epidemiological investigation and analysis of the genetic evolution of duck circovirus in China, 2022. PLoS ONE. 20(5). e0323282–e0323282.
3.
Shen, Ke, Dandan Shen, Yi‐Chao Zheng, et al.. (2023). High-fat diet promotes tumor growth in the patient-derived orthotopic xenograft (PDOX) mouse model of ER positive endometrial cancer. Scientific Reports. 13(1). 16537–16537. 3 indexed citations
4.
Zhao, Xinyue, Li Yang, Yuanhang Zhu, et al.. (2022). EphA2 Promotes the Development of Cervical Cancer through the CXCL11/PD-L1 Pathway. Journal of Oncology. 2022. 1–17. 3 indexed citations
5.
Yang, Jing, Yang Li, Ji-Hak Jeong, et al.. (2022). Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer. Frontiers in Pharmacology. 12. 785981–785981. 18 indexed citations
6.
Wang, Nannan, Zhenan Zhang, Ke Shen, et al.. (2022). PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies. Frontiers in Pharmacology. 13. 967633–967633. 23 indexed citations
7.
Jin, Ziyang, Ke Shen, Xingtang Fang, et al.. (2019). TiO2 nanotubes promote osteogenic differentiation of mesenchymal stem cells via regulation of lncRNA CCL3-AS. Colloids and Surfaces B Biointerfaces. 181. 416–425. 10 indexed citations
8.
Xu, Ke, Ke Shen, Xin Liang, et al.. (2016). MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Oncotarget. 7(46). 75118–75129. 36 indexed citations
9.
Yang, Liyan, Ke Shen, Li Ma, et al.. (2015). A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells. Biomedicine & Pharmacotherapy. 71. 70–78. 17 indexed citations
10.
Ma, Li, Ke Shen, Yuanhong Zheng, et al.. (2014). Atractylenolide I-mediated Notch pathway inhibition attenuates gastric cancer stem cell traits. Biochemical and Biophysical Research Communications. 450(1). 353–359. 40 indexed citations
11.
Li, Qifeng, et al.. (2013). MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. Journal of Translational Medicine. 11(1). 302–302. 43 indexed citations
12.
Shen, Ke, Huanying Zhang, Yufang Xu, et al.. (2013). A ROS-mediated lysosomal–mitochondrial pathway is induced by a novel Amonafide analogue, 7c, in human Hela cervix carcinoma cells. Cancer Letters. 333(2). 229–238. 27 indexed citations
13.
14.
Xu, Ke, Xin Liang, Ke Shen, et al.. (2012). MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17. Experimental Cell Research. 318(17). 2168–2177. 62 indexed citations
15.
Shen, Ke, et al.. (2012). Inhibition of IGF‐IR increases chemosensitivity in human colorectal cancer cells through MRP‐2 promoter suppression. Journal of Cellular Biochemistry. 113(6). 2086–2097. 37 indexed citations
16.
Shen, Ke, Ke Xu, Lin Jiang, et al.. (2012). MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochemical Pharmacology. 84(3). 320–330. 130 indexed citations
17.
Shao, Jin, et al.. (2012). E2F1‐dependent pathways are involved in amonafide analogue 7‐d‐induced DNA damage, G2/M arrest, and apoptosis in p53‐deficient K562 cells. Journal of Cellular Biochemistry. 113(10). 3165–3177. 8 indexed citations
18.
Shen, Ke & Raymond Novak. (1997). DDT Stimulates c-erbB2, c-met, and STATS Tyrosine Phosphorylation, Grb2-Sos Association, MAPK Phosphorylation, and Proliferation of Human Breast Epithelial Cells. Biochemical and Biophysical Research Communications. 231(1). 17–21. 39 indexed citations
19.
Shen, Ke & Raymond Novak. (1997). Differential Effects of Aroclors and DDT on Growth Factor Gene Expression and Receptor Tyrosine Kinase Activity in Human Breast Epithelial Cells. Advances in experimental medicine and biology. 407. 295–302. 9 indexed citations
20.
Shen, Ke & Raymond Novak. (1997). Fas-Signaling and Effects on Receptor Tyrosine Kinase Signal Transduction in Human Breast Epithelial Cells. Biochemical and Biophysical Research Communications. 230(1). 89–93. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dapeng Ding Breakdown of academic impact, for papers by Chuangyu Wen Breakdown of academic impact, for papers by Wuguo Li Breakdown of academic impact, for papers by Ming‐De Yan Breakdown of academic impact, for papers by Sabnam Parbin Breakdown of academic impact, for papers by Pingli Mo Breakdown of academic impact, for papers by Yujie Sun Breakdown of academic impact, for papers by Xiaohua Zhang Breakdown of academic impact, for papers by Yidi Guan
Rankless by CCL
2026